PMID- 29326972
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220410
IS  - 2352-5789 (Print)
IS  - 2352-5789 (Electronic)
IS  - 2352-5789 (Linking)
VI  - 23
DP  - 2018 Feb
TI  - Aggressive neuroendocrine tumor of the ovary with multiple metastases treated 
      with everolimus: A case report.
PG  - 20-23
LID - 10.1016/j.gore.2018.01.002 [doi]
AB  - *Neuroendocrine tumors (NETs) frequently occur in the lungs or the 
      gastrointestinal tract; they are uncommon in the ovary.*The mammalian target of 
      rapamycin (mTOR) pathway has been reported as a treatment for advanced NETs.*We 
      describe a patient with an aggressive primary ovarian NET, successfully treated 
      with everolimus (an mTOR inhibitor).
FAU - Kaiho-Sakuma, Michiko
AU  - Kaiho-Sakuma M
AD  - Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, 
      Japan.
FAU - Toyoshima, Masafumi
AU  - Toyoshima M
AD  - Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, 
      Japan.
FAU - Watanabe, Mika
AU  - Watanabe M
AD  - Department of Pathology, Tohoku University Hospital, Sendai, Japan.
FAU - Toki, Asami
AU  - Toki A
AD  - Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, 
      Japan.
FAU - Kameda, Satomi
AU  - Kameda S
AD  - Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, 
      Japan.
FAU - Minato, Takamichi
AU  - Minato T
AD  - Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, 
      Japan.
FAU - Niikura, Hitoshi
AU  - Niikura H
AD  - Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, 
      Japan.
FAU - Yaegashi, Nobuo
AU  - Yaegashi N
AD  - Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, 
      Japan.
LA  - eng
PT  - Case Reports
DEP - 20180104
PL  - Netherlands
TA  - Gynecol Oncol Rep
JT  - Gynecologic oncology reports
JID - 101652231
PMC - PMC5760241
OTO - NOTNLM
OT  - BEP, bleomycin, etoposide, and cisplatin
OT  - CA-125, carbohydrate antigen 125
OT  - CD56, cluster of differentiation 56
OT  - CDX2, caudal-type homeobox transcription factor 2
OT  - CT, computed tomography
OT  - Carcinoid
OT  - EMA, epithelial membrane antigen
OT  - Everolimus
OT  - FIGO, International Federation of Gynecology and Obstetrics
OT  - MRI, magnetic resonance imaging
OT  - Multiple metastases
OT  - NETs, neuroendocrine tumors
OT  - Neuroendocrine tumor
OT  - Ovary
OT  - mTOR, mammalian target of rapamycin
EDAT- 2018/01/13 06:00
MHDA- 2018/01/13 06:01
PMCR- 2018/01/04
CRDT- 2018/01/13 06:00
PHST- 2017/11/29 00:00 [received]
PHST- 2018/01/01 00:00 [revised]
PHST- 2018/01/03 00:00 [accepted]
PHST- 2018/01/13 06:00 [entrez]
PHST- 2018/01/13 06:00 [pubmed]
PHST- 2018/01/13 06:01 [medline]
PHST- 2018/01/04 00:00 [pmc-release]
AID - S2352-5789(18)30002-X [pii]
AID - 10.1016/j.gore.2018.01.002 [doi]
PST - epublish
SO  - Gynecol Oncol Rep. 2018 Jan 4;23:20-23. doi: 10.1016/j.gore.2018.01.002. 
      eCollection 2018 Feb.